<DOC>
	<DOCNO>NCT01882062</DOCNO>
	<brief_summary>The purpose project study efficacy anaplerotic treatment brain energy profile evolution early stage Huntington disease .</brief_summary>
	<brief_title>Proof Concept Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy Huntington Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>5 &lt; UHDRS &lt; 50 Age &gt; 18 year Ability undergo MR scanning Covered french social security Evidence psychiatric disorder Attendant neurological disorder Contraindications MRI ( claustrophobia , metallic material implant ) Severe head injury Unable understand protocol Pregnancy Failure give informed consent Subjects exclusion criterion require french law ( e.g . subject require legally authorize representative obtain consent ) Unwillingness inform case abnormal MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>